AVTR · Avantor, Inc.
$11.35
+3.65% last session
End-of-day data · updated 2026-07-25
Market cap
$8B
Enterprise value
$11B
Trailing P/E
—
Forward P/E
13.4
Dividend yield
—
Beta
0.94
Avg volume
10M
Employees
14K
2D change
0.79%
5D change
7.32%
10D change
2.14%
30D change
13.49%
60D change
40.54%
MTD change
14.29%
YTD change
-0.17%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — AVTR
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-08
Latest call per bank · past 12 months
Citigroup
Neutral$11.00
-3.1% vs priceBarclays
Underweight$8.00
-29.5% vs priceWells Fargo
Overweight$14.00
+23.3% vs priceJefferies
Underperform$9.00
-20.7% vs priceJP Morgan
Neutral$12.00
+5.7% vs priceMorgan Stanley
Equal-Weight$12.00
+5.7% vs priceRBC Capital
Outperform$17.00
+49.8% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-08 | Citigroup | Maintains | Neutral | $9.00 → $11.00 |
| 2026-07-06 | Evercore ISI Group | Maintains | In-Line | $8.00 → $10.50 |
| 2026-06-24 | Barclays | Maintains | Underweight | $7.00 → $8.00 |
| 2026-04-30 | Citigroup | Maintains | Neutral | $11.00 → $9.00 |
| 2026-04-30 | Evercore ISI Group | Maintains | In-Line | $8.50 → $8.00 |
| 2026-04-15 | Barclays | Maintains | Underweight | $8.50 → $7.00 |
| 2026-04-06 | Evercore ISI Group | Maintains | In-Line | $10.00 → $8.50 |
| 2026-03-06 | Barclays | Downgrade | Equal-Weight → Underweight | $0.00 → $8.50 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-23
- RSI (14): RSI is 65 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 18.9% above the 50-day MA ($9.55).
- Price vs 200-day MA: Trading 10.7% above the 200-day MA ($10.25).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is positive (+0.01) — short-term momentum is improving.
- 52-week range: Price sits between the 52-week low ($7.41) and high ($15.60).
AVTR Price Chart
Loading chart for AVTR…
Fundamentals
About Avantor, Inc.
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
More in Medical Instruments & Supplies
ISRG
Intuitive Surgical, Inc.
$121B -40.4% YTD
MDLN
Medline Inc.
$69B -7.7% YTD
BDX
Becton, Dickinson and Company
$43B 3.9% YTD
ALC
Alcon Inc.
$33B -13.4% YTD
RMD
ResMed Inc.
$28B -18.5% YTD
WST
West Pharmaceutical Services, I
$23B 19.5% YTD
COO
The Cooper Companies, Inc.
$14B -14.2% YTD
SOLV
Solventum Corporation
$14B -1.6% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.